Therapeutic antibody against muc-1 antigen and methods for their use
CA 2380936 A1 · Owner: Madiyalakan, Ragupathy · Inventors: Madiyalakan, Ragupathy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides therapeutic compositions comprising binding agents that specifically bind to tumor-associated MUC-1 and reduce reverse or prevent , their effects in cancer. More particularly the invention provides therapeutic , compositions that comprise a binding agent that can specifically bind to an epitope that comprises both peptide and carbohydrate on such tumor-associated MUC-1. The invention further provides methods for the use of such therapeutic compositions in the treatment of cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.